Independent walk in osteogenesis imperfecta

Acta Ortopedica Brasileira

Volumn 19, Issue 5, 2011, Pages 312-315

  Moreira, Carmem Lia Martins ^a   Lima, Maria Angelica de Faria Domingues ^b   Cardoso, Maria Helena Cabral de Almeida ^a   Gomes Junior, Saint Clair dos Santos ^a   Lopes, Paula Bacellar ^a   Llerena Junior, Juan Clinton ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Cross sectional studies; Gait; Mobility limitation; Osteogenesis imperfecta; Physical therapy

Indexed keywords

EID: 83755206891     PISSN: 14137852     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-78522011000500010     Document Type: Article

References (20)

1. Engelbert RHH, Uiterwaal CS, Grever WJ, van der Net JJ, Pruijs HE, Helders PJ. Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up. Arch Phys Med Rehabil. 2004;85:772-8.
2. Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P et al. Type V osteogenesis imperfecta: a new form of brittle bone disease. J Bone Miner Res. 2000;15:1650-8.
3. Glorieux FH, Ward LM, Rauch F, Lalic L, Roughley PJ, Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralisation defect.J Bone Miner Res. 2002;17:30-8.
4. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta.J Med Genet. 1979;16:101-16.
5. Ward LM, Rauch F, Travers R, Chabot G, Azouz EM, Lalic L et al. Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease.Bone. 2002;31: 12-8.
6. Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S et al. Prolyl3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe Osteogenesis imperfecta. Nat Gen. 2007; 39:359-65.
7. Engelbert RH, Beemer FA, van der Graaf Y, Helders PJ. Osteogenesis imperfecta in childhood: impairment and disability - A follow-up study. Arch Phys Med Rehabil. 1999;80:896-903.
8. Ratliffe KT. Fisioterapia - clínica pediátrica. São Paulo: Editora Santos; 2000.
9. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363:1377-85.
10. Lopes PB. Estudo sobre desenvolvimento motor grosso de crianças do Centro de Referência para osteogênese imperfeita do Instituto Fernandes Figueira/FIOCUZ/RJ [dissertação]. Rio de Janeiro: Instituto Fernandes Figueira; 2009.
11. Dubowitz V. El nino hipotônico. Barcelona: Editorial Pediátrica; 1973.
12. Reed UC. Síndrome da criança hipotônica. In: Diament AG, Cypel S, organizadores. Neurologia infantil. 3a. ed. São Paulo: Atheneu; 1996. p 1130-54.
13. Munns CFJ, Sillence DO. Disorders predisposing to bone fragility and decreased bone density In: Emery and Rimoin's principles and practice of medical genetics. 5th ed. Philadephia: Churchill Livingstone; 2007. p. 3671-91.
14. Gosselin J, Amiel-Tison C. Avaliação Neurológica: do nascimento aos 6 anos.2a. ed. Porto Alegre: Artmed; 2009.
15. Umphred DA. Reabilitação neurológica. 4a. ed. Barueri: Manole; 2004.
16. Vetter U, Pontz B, Zauner E, Brenner RE, Spranger J. Osteogenesis imperfecta:a clinical study of the first ten years of life. Calcif Tissue Int. 1992; 50:36-41.
17. Flehmig I. Texto e atlas do desenvolvimento normal e seus desvios no lactente..São Paulo: Atheneu; 2002.
18. Hernandez CJ, Keaveny TM. A biomechanical perspective on bone quality.Bone. 2006;39:1173-81.
19. Aström E, Söderhäll S. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Pædiatr. 1998;87: 64-8.
20. Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.N Eng J Med. 1998;339:947-52.